biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > SH is upgrading their Bullboard protocols!!!,,Beware!!

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Nov 20, 2022 4:29pm

100 Views

Post# 35114112

RE:SH is upgrading their Bullboard protocols!!!,,Beware!!

Also part of the new TOU policing on SH:

We Need Your Help

Even with the changes we're making, you, as a member of Stockhouse, can help us out. We can't review every post, therefore, you're part of the solution in helping us weed out that undesirable content. You can:

Familiarize yourself with our Community Policies
See something, say something. Use the Report Abuse button when you see content that's questionable. If you report it, we'll review it.
If you choose to use our Ignore User function, please also Report Abuse on any content that may have lead you to making that choice